LLY

#12
Eli Lilly & Co.
934.55 USD
+0.57%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
933.81
935.53
Intervallo Annuale
644.51
1 133.95
Variazione giornaliera
+0.57%
Variazione Mensile
-5.87%
Variazione di 6 mesi
+15.02%
Variazione Annuale
+23.63%
Chiusura Precedente
929.23
Apertura
934.63
Bid
Ask
Minimo
933.81
High
935.53
Volume
466
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 881.61 B
  • Employee 50 K
  • Founded N/A
  • CEO David A. Ricks
  • Website www.lilly.com
  • Headquarter Indiana, United States
  • FIGI BBG000BNBDC2
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
46.83
Rapporto prezzo/fatturato
14.83
Dividendi per azione
6.23
Rendimento da dividendi %
0.58

Eli Lilly and Company

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named. The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.

Notizie